Investigation of awareness rate of prostate-specific antigen (PSA) among the general public in China and analysis of influencing factors by Yuqin Wang, Mukun Xiao, Yueying Zhang, Zhiwei Hong, Zhiwei Hong, Ruochen Zhang, Ruochen Zhang, Qingjiang Xu, Qingjiang Xu, Le Lin, Le Lin, Yongbao Wei, Yongbao Wei

Connect to this object online.

Disitamab vedotin in combination with immune checkpoint inhibitors for locally and locally advanced bladder urothelial carcinoma: a two-center's real-world study by Yongbao Wei, Yongbao Wei, Ruochen Zhang, Ruochen Zhang, Chenbo Yu, Chenbo Yu, Zhiwei Hong, Zhiwei Hong, Le Lin, Le Lin, Tao Li, Tao Li, Jianhui Chen

Connect to this object online.

UBC Mediated by SEPT6 Inhibited the Progression of Prostate Cancer by Ruochen Zhang, Yaojing Yang, Haijian Huang, Tao Li, Liefu Ye, Le Lin, Yongbao Wei

Connect to this object online.

Androgen deprivation therapy plus apalutamide as neoadjuvant therapy prior radical prostatectomy for patients with unresectable prostate cancer by Yongbao Wei, Yongbao Wei, Ruochen Zhang, Ruochen Zhang, Dewen Zhong, Zhensheng Chen, Gen Chen, Minggen Yang, Le Lin, Le Lin, Tao Li, Tao Li, Liefu Ye, Liefu Ye, Lili Chen, Lili Chen, Qingguo Zhu, Qingguo Zhu

Connect to this object online.